Company: OTSA
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061733
Chunk: 162

Company: OTSAW Ltd
Filing Date: 2025-07-07
Form: F-1/A
Chunk 162
---
RXproduct line has since been discontinued, and only a total of 3 TreX products has been sold as of the date of this prospectus. The costs associated with the filing of the patents were shared equally by the parties. We also agreed to pay SIMTech a royalty fee in connection with the use of the technology. To date, the aggregate amount of project -relatedpayments made by us under the RCA is approximately US$32,700 (S$43,157), and the agreed royalty fee paid or payable is approximately US$33,800 (S$44,593). We continue to grow through allying with channel partners and strategic investors globally, enabling us to be more agile in achieving our goals in the shortest time by leveraging on our technological strength and our partners’ connections and relationship. We plan to pursue strategic co -developmentopportunities and arrangements that further enhance our product pipeline to create effective synergies to supplement our AMRs and robotics ecosystem. Our collaborations with industry players provide valuable knowledge that we believe will enhance our early mover advantage. Growth Strategies Developing Our Core Software Technologies and Commercialize Our Up-and -Coming ANS Version 3, the Odyssey, to the Entire AMR and Robotics Industry We will continue to make significant investments in research and development to upgrade and “future -proof” our products and our core software technologies. Specifically, we are in the research and development stage to upgrade our proprietary robotics software technology, the ANS, from its Version 2 to Version 3. As of the date of this prospectus, our revenue substantially centers around our AMR and robotics products embedded with our ANS Version 1 and Version 2. We are in the early research and development stage to independently commercialize and market the ANS Version3, as the software solution that will provide the foundational outdoor and indoor autonomy capability for third -partyAMR products and robotic platforms, under the product brand “Odyssey”. We have started commercialization of ANS Version 2 in 2025, and are in the process of collecting more data and feedback from the use of ANS Version 1 and Version 2 to improve the Odyssey. We expect to commence the development of ANS Version 3 in 2026, with a target to launch in 2028. We intend for the Odyssey to go far beyond application within our in -houseAMRs and robotic products. We believe the Odyssey, which is empowered by our cutting edge outdoor autonomous software capabilities, will unlock the industry -wideapplication and tremendous monetization opportunities